Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
Holders of 5% or more of PHAR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pharming Group N.V., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Pharming Group N.V. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Pharming Group N.V., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 7, 20254:04 PM ET | Morgan Stanley | 13G/A | 1.20%8.47M shares | –Below 5% | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Pharming Group N.V. shares.
No Form 144 notices for Pharming Group N.V. are on file.